Used by millions of patients every year, Phreesia is an optimal platform for engaging patients in their own healthcare. During check-in, patients enter their complete demographic and clinical information on the PhreesiaPad, which triggers questions specifically targeted toward their current health status. In this way, Phreesia is able to elicit comprehensive responses from patients, while providing them with the utmost privacy and security. With its growing library of assessments, which includes asthma, autism and sleep disorders, Phreesia is an ideal platform for administering clinical screenings to patients.
Phreesia CEO Chaim Indig remarks, "Phreesia is proud to support National Depression Screening Day with the electronic version of the PHQ-9. Early detection is critical to improving healthcare outcomes and, through our unique patient-engagement platform and our growing library of health screenings, Phreesia is taking an active role in providing a vital public health service that helps medical practices achieve positive results for their patients."
The PHQ-9 is licensed to Phreesia through a separate agreement with Pfizer, Inc. PHQ © 1999 Pfizer, Inc. All rights reserved.
Phreesia, the patient check-in company, streamlines the patient check-in process, helping medical practices increase cash flow and save staff time. With its wireless, touchscreen PhreesiaPad, the solution allows medical practices to collect patient information effortlessly, electronically verify insurance and collect payments both at the point of care and outside of the office. Phreesia delivers fully interactive content direct to patients, and is design
Copyright©2010 PR Newswire.
All rights reserved